LifeGuide

Color Blind A new report documents racism and xenophobia in HIV non-disclosure media coverage in Canada by Larry Buhl A new report documents the anti-Black and anti-immigrant...

Hep Talk by Larry Buhl Location, Location, Location How will the Affordable Care Act affect HCV care? In October, open enrollment for state-based health insurance marketplaces as...

LifeGuide HIV drug development faces challenges by Jeannie Wraight and Mariel Selbovitz, MPH Triple and now quad drugs like Gilead’s Atripla and their new compound known...

Undetectable is a worthy goal, no doubt about it. A suppressed viral load very often means the individual living with HIV is adherent to...

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C...

Preparing for the Worst HIV/AIDS advocates say PrEP access would be a casualty of ACA replacement by Larry Buhl The GOP replacement for the Affordable Care Act...

One Drug, Many Possibilities A new agent may assist in the fight against HIV and other viruses by Jeannie Wraight Every once in a while I come...

Remembering Olvidados Working with community-based organizations and clinics across the nation, the Latino Commision on AIDS, in partnership with the Hispanic Health Network, recently released...

LifeGuide Two Birds, One Stone Researchers make advances with agents that can target dual points of entry by Mariel Selbovitz, MPH Drug discovery and early to mid-stage drug...

Amy Killelea of the National Alliance of State and Territorial AIDS Directors (NASTAD) sees healthcare coverage gaps everywhere, and as director of NASTAD’s new...